FLAT 15% MEDICARE REBATE FOR BRANDNAMES ADOPTED BY WAYS & MEANS COULD BE VIABLE, ATTRACTIVE ALTERNATIVE FOR BRAND FIRMS; PRYOR SEEKS 17% BRAND REBATES
Executive Summary
The 15% flat rebate for brandname products adopted by the House Ways & Means Committee on June 21 could cost the brandname sector as much as $11 bil. between 1997-2003 in rebates on drugs for the over-65 population but it also could create three major areas of savings for brand marketers.